AMLN (DIABETES DRUGS) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AMLN (DIABETES DRUGS)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: MulhollandDrive who wrote (415)	8/17/1997 5:45:00 PM
From: Henry Niman	of 2173

bp, As I said on the LGND thread, AMLN's data could be used as a plus for LGND, but that was a stretch. More likely, it could pull down the entire sector because it wasn't good news. I just checked AMLN's recs in Zacks. As I recall, it used to be the #1 Biotech with 5 strong buys. Currently it was 2 Strong Buys and 4 Buys (not sure if latest rec is included) placing it in the middle of Biotechs (65/115?).

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next